Russian state to provide additional subsidies to domestic developers of original drugs

The Russian government has proposed a new mechanism for subsidization of works for development of new drugs, reports The Pharma Letter’s local correspondent.

As part of these plans, the government will provide grants of up to 250 million roubles ($80.8 million) to companies that already have a registration certificate for their drugs and are ready to conduct clinical trials.

In this case, the government will reimburse them at least part of their costs for organizing their final phase. According to the Russian Ministry of Industry and Trade, all the subsidies will be provided from the state budget under the federal project "Support for Research and Development in Civilian Industries". In 2026, its budget will amount to over 1.6 trillion roubles.